Didier Bazile

2.4k total citations · 1 hit paper
32 papers, 1.9k citations indexed

About

Didier Bazile is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Didier Bazile has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomaterials, 14 papers in Molecular Biology and 12 papers in Pharmaceutical Science. Recurrent topics in Didier Bazile's work include Nanoparticle-Based Drug Delivery (13 papers), Advanced Drug Delivery Systems (11 papers) and Drug Solubulity and Delivery Systems (7 papers). Didier Bazile is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Advanced Drug Delivery Systems (11 papers) and Drug Solubulity and Delivery Systems (7 papers). Didier Bazile collaborates with scholars based in France, Germany and Ireland. Didier Bazile's co-authors include M. Veillard, G. Spenlehauer, Patrick Couvreur, L. Harivardhan Reddy, Christine Vauthier, Jean–Louis Grossiord, F. Puisieux, Denis Labarre, Catherine Ropert and Armand Frydman and has published in prestigious journals such as Nucleic Acids Research, Biomaterials and Chemistry of Materials.

In The Last Decade

Didier Bazile

32 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System

1995 510 citations Didier Bazile, G. Spenlehauer et al. Journal of Pharmaceutical Sciences profile →

Peers

Countries citing papers authored by Didier Bazile

Since Specialization

Citations

This map shows the geographic impact of Didier Bazile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Bazile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Bazile more than expected).

Fields of papers citing papers by Didier Bazile

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Bazile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Bazile. The network helps show where Didier Bazile may publish in the future.

Co-authorship network of co-authors of Didier Bazile

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Bazile. A scholar is included among the top collaborators of Didier Bazile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Bazile. Didier Bazile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Silica-Coated Nanoparticles with a Core of Zinc, l-Arginine, and a Peptide Designed for Oral Delivery 2019 ·ACS Applied Materials & Interfaces ·Delyan R. Hristov, Fiona McCartney, (unknown), Eugene Mahon, (unknown), Sourav Bhattacharjee, Géraldine Pénarier, Werner Ulrich, Didier Bazile, David J. Brayden	25
2	Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin 2018 ·Journal of Controlled Release ·(unknown), Fiona McCartney, Eric Sultan, (unknown), (unknown), Clara V. Álvarez, Werner Ulrich, Didier Bazile, David J. Brayden, Caitríona M. O’Driscoll	48
3	Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))–poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint 2016 ·Advanced Drug Delivery Reviews ·(unknown), Didier Bazile	32
4	Oral delivery of diabetes peptides — Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context 2016 ·Advanced Drug Delivery Reviews ·(unknown), Matthias Urmann, (unknown), Werner Ulrich, Torsten Haack, (unknown), (unknown), Brigitte Illel, (unknown), (unknown), Didier Bazile	56
5	A method to Quantify the Affinity of Cabazitaxel for PLA-PEG Nanoparticles and Investigate the Influence of the Nano-Assembly Structure on the Drug/Particle Association 2015 ·Pharmaceutical Research ·Odile Diou, (unknown), (unknown), D. Lairez, Jean‐René Authelin, Didier Bazile	20
6	Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics 2013 ·Advanced Drug Delivery Reviews ·L. Harivardhan Reddy, Didier Bazile	69
7	Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying 2005 ·Pharmaceutical Research ·(unknown), Didier Bazile	37
8	Peroral Administration of¹⁴C-Poly(D,L-Lactic Acid) Nanoparticles Coated with Human Serum Albumin or Polyvinyl Alcohol to Guinea Pigs 1998 ·Journal of drug targeting ·France Landry, Didier Bazile, G. Spenlehauer, M. Veillard, (unknown)	21
9	Release of the fluorescent marker Prodan® from poly(D,L-lactic acid) nanoparticles coated with albumin or polyvinyl alcohol in model digestive fluids (USP XXII) 1997 ·Journal of Controlled Release ·France Landry, Didier Bazile, G. Spenlehauer, M. Veillard, J. Kreuter	31
10	Encapsulation of oligonucleotides in stealth Me.PEG-PLA₅₀nanoparticles by complexation with structured oligopeptides 1996 ·Drug Delivery ·(unknown), Didier Bazile, Frédéric Herman, Claude Hélène, M. Veillard	24
11	Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators 1996 ·Biomaterials ·(unknown), Didier Bazile, G. Spenlehauer, (unknown), M. Veillard, F. Puisieux, Denis Labarre	158
12	Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System breakdown → 1995 ·Journal of Pharmaceutical Sciences ·Didier Bazile, (unknown), (unknown), (unknown), G. Spenlehauer, M. Veillard	510
13	Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process 1993 ·Journal of Biomedical Materials Research ·(unknown), (unknown), Didier Bazile, M. Veillard, G. Spenlehauer, Patrick Couvreur	71
14	Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats 1992 ·Biomaterials ·Didier Bazile, Catherine Ropert, (unknown), (unknown), (unknown), Armand Frydman, M. Veillard, G. Spenlehauer	150
15	Structural features associated with α- anomerie in oligo-α-thymidylates 1990 ·Biochemical and Biophysical Research Communications ·Jean‐Rémi Bertrand, Didier Bazile, Claude Malvy, Jacques Paoletti	4
16	An ellipticine derivative (oxazolopyridocarbazolium) 3′ linked to tetrathymidylate stacks intramolecularly with the nearest thymine at low concentration and head‐to‐tail intermolecularly at high concentration 1990 ·Biopolymers ·Didier Bazile, Éric Guittet, (unknown), Marius Lebret, Jacques Paoletti	2
17	α-DNA X:αandβtetrathymidilates covalently linked to oxazolopyridocarbazolium (OPC): comparative stabilization of oiigoβ-[dT]:oligoβ-[dA] and oligoα-[dT]:oligoβ-[dA] duplexes by the intercalating agent 1989 ·Nucleic Acids Research ·Didier Bazile, (unknown), Bernard Rayner, Jean‐Louis Imbach, Claude Paoletti, Jacques Paoletti	9
18	α-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: α-d(GGAAGG) and α-d(CCTTCC) and their complementary oligo-beta-deoxynucleotides: β-d(CCTTCC) and β-d(GGAAGG) are different 1989 ·Nucleic Acids Research ·Jacques Paoletti, Didier Bazile, F. Morvan, Jean‐Louis Imbach, Claude Paoletti	43
19	Voltage-dependent introduction of a d[α]octothymidylate into electropermeabilized cells 1989 ·Biochemical and Biophysical Research Communications ·Didier Bazile, Lluis M. Mir, Claude Paoletti	19
20	Poly(rA) binding of α-anomeric and β-anomeric tetrathymidylates covalently linked to an intercalating oxazolopyridocarbazolium. Determination of the binding parameters 1988 ·Biochemical and Biophysical Research Communications ·(unknown), Didier Bazile, Jacques Paoletti	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact